154 related articles for article (PubMed ID: 23359888)
1. Contemporary treatment of low risk stage I non-seminomatous germ cell testicular tumors: a survey of the Society of Urologic Oncology.
Alanee S; Nicholson A; Slaton J
Urol Oncol; 2012; 30(6):749-51. PubMed ID: 23359888
[No Abstract] [Full Text] [Related]
2. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.
Kamran SC; Seisen T; Markt SC; Preston MA; Trinh QD; Frazier LA; Choueiri TK; Martin NE; Nguyen PL; Beard CJ
Eur Urol; 2018 Feb; 73(2):262-270. PubMed ID: 28687143
[TBL] [Abstract][Full Text] [Related]
3. Treatment of non-seminomatous testicular germ cell tumors in Denmark since 1979.
Rørth M; von der Maase H; Nielsen ES; Schultz H; Pedersen M
Prog Clin Biol Res; 1985; 203():539-51. PubMed ID: 3008183
[No Abstract] [Full Text] [Related]
4. Accuracy of clinical staging and efficacy of treatment in non-seminomatous germ-cell tumours of the testis.
de Kock ML; Allen FJ; Breytenbach IH; van der Merwe AM
S Afr J Surg; 1987 Sep; 25(3):87-9. PubMed ID: 2825363
[No Abstract] [Full Text] [Related]
5. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.
Yap SA; Yuh LM; Evans CP; Dall'Era MA; Wagenaar RM; Cress R; Lara PN
World J Urol; 2017 Feb; 35(2):277-283. PubMed ID: 27306686
[TBL] [Abstract][Full Text] [Related]
6. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
7. Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option.
Hamilton RJ; Jewett MAS; Warde P; Hansen A
Eur Urol Focus; 2019 Sep; 5(5):702-703. PubMed ID: 31129064
[TBL] [Abstract][Full Text] [Related]
8. Testicular cancer. Clinical practice guidelines in oncology.
Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
[No Abstract] [Full Text] [Related]
9. [Treatment strategy for stage I testicular germ cell tumor].
Nakai Y; Nagahara A; Uemura M; Takayama H; Nonomura N
Hinyokika Kiyo; 2012 Dec; 58(12):715-20. PubMed ID: 23328172
[TBL] [Abstract][Full Text] [Related]
10. Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
[TBL] [Abstract][Full Text] [Related]
11. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
12. Non-seminomatous germ cell testis tumors--how do you manage clinical state IIA?
Whitmore WF
Prog Clin Biol Res; 1985; 203():571-4. PubMed ID: 3008185
[No Abstract] [Full Text] [Related]
13. Controversies in the management of clinical stage I nonseminomatous germ cell testicular cancer.
Ondrus D; Kajo K; Stastna V; Ondrusova M
Klin Onkol; 2015; 28(2):112-5. PubMed ID: 25882021
[TBL] [Abstract][Full Text] [Related]
14. Testicular cancer guideline adherence and patterns of care in Germany: A nationwide survey.
Nestler T; Baunacke M; Dräger D; von Landenberg N; Groeben C; Huber J
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12917. PubMed ID: 30252174
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of localized, non-seminomatous, germinal tumors of the testis].
Lortholary O; Goupil A
Ann Med Interne (Paris); 1991; 142(4):245-7. PubMed ID: 1656831
[No Abstract] [Full Text] [Related]
16. Management of patients with non-seminomatous germ cell tumours stage I.
Rørth M; Cullen MH; Horwich A; Roth BJ
Prog Clin Biol Res; 1990; 357():295-303. PubMed ID: 2170995
[No Abstract] [Full Text] [Related]
17. Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A review.
Droz JP; van Oosterom AT
Eur J Cancer; 1993; 29A(7):1038-44. PubMed ID: 8388697
[No Abstract] [Full Text] [Related]
18. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Huddart R; Kataja V;
Ann Oncol; 2008 May; 19 Suppl 2():ii52-4. PubMed ID: 18456768
[No Abstract] [Full Text] [Related]
19. Germ Cell Testicular Tumors-Contemporary Diagnosis, Staging and Management of Localized and Advanced disease.
Goldberg H; Klaassen Z; Chandrasekar T; Fleshner N; Hamilton RJ; Jewett MAS
Urology; 2019 Mar; 125():8-19. PubMed ID: 30597167
[TBL] [Abstract][Full Text] [Related]
20. Current management of stage I testicular non-seminomatous germ cell tumours.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
